Header Logo

Connection

ANNA MANDALAKAS to Antitubercular Agents

Back to Details
This is a "connection" page, showing publications ANNA MANDALAKAS has written about Antitubercular Agents.
ANNA MANDALAKAS
Connection Strength
3.290
Antitubercular Agents
  1. HIV-associated pediatric tuberculosis: prevention, diagnosis and treatment. Curr Opin HIV AIDS. 2018 11; 13(6):501-506.
    View in: PubMed
    Score: 0.512
  2. Pasting together the preventive therapy puzzle. Int J Tuberc Lung Dis. 2013 Feb; 17(2):175-7.
    View in: PubMed
    Score: 0.340
  3. Recording isoniazid preventive therapy delivery to children: operational challenges. Int J Tuberc Lung Dis. 2010 May; 14(5):650-3.
    View in: PubMed
    Score: 0.284
  4. Emerging bedaquiline-resistant tuberculosis. Lancet Microbe. 2023 12; 4(12):e964-e965.
    View in: PubMed
    Score: 0.181
  5. Tuberculosis prevention in children: a prospective community-based study in South Africa. Eur Respir J. 2021 04; 57(4).
    View in: PubMed
    Score: 0.152
  6. Perspective for Precision Medicine for Tuberculosis. Front Immunol. 2020; 11:566608.
    View in: PubMed
    Score: 0.146
  7. It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV. Am J Trop Med Hyg. 2020 10; 103(4):1348-1349.
    View in: PubMed
    Score: 0.146
  8. Management of drug-resistant tuberculosis. Lancet. 2019 09 14; 394(10202):953-966.
    View in: PubMed
    Score: 0.136
  9. Management of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2019 06 01; 23(6):645-662.
    View in: PubMed
    Score: 0.133
  10. High Incidence of Tuberculosis Infection in HIV-exposed Children Exiting an Isoniazid Preventive Therapy Trial. Pediatr Infect Dis J. 2018 10; 37(10):e254-e256.
    View in: PubMed
    Score: 0.127
  11. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network. J Acquir Immune Defic Syndr. 2017 Jun 01; 75(2):156-163.
    View in: PubMed
    Score: 0.116
  12. Culture is an imperfect and heterogeneous reference standard in pediatric tuberculosis. Tuberculosis (Edinb). 2016 12; 101S:S105-S108.
    View in: PubMed
    Score: 0.111
  13. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax. 2013 Mar; 68(3):247-55.
    View in: PubMed
    Score: 0.082
  14. Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection. Int J Tuberc Lung Dis. 2012 Aug; 16(8):1033-9.
    View in: PubMed
    Score: 0.082
  15. Operational challenges in managing Isoniazid Preventive Therapy in child contacts: a high-burden setting perspective. BMC Public Health. 2011 Jul 08; 11:544.
    View in: PubMed
    Score: 0.077
  16. Opportunities for chemoprophylaxis in children with culture-confirmed tuberculosis. Ann Trop Paediatr. 2011; 31(4):301-10.
    View in: PubMed
    Score: 0.074
  17. Current concepts of childhood tuberculosis. Semin Pediatr Infect Dis. 2005 Apr; 16(2):93-104.
    View in: PubMed
    Score: 0.050
  18. Tuberculosis in adult migrants in Europe: a TBnet consensus statement. Eur Respir J. 2025 Mar; 65(3).
    View in: PubMed
    Score: 0.050
  19. A novel method for detecting Lipoarabinomannan in urine with the promise of meeting the WHO target product profile for the diagnosis of tuberculosis. Tuberculosis (Edinb). 2025 May; 152:102619.
    View in: PubMed
    Score: 0.050
  20. High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered? Infection. 2025 Aug; 53(4):1501-1506.
    View in: PubMed
    Score: 0.049
  21. Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers. AIDS Res Ther. 2024 Aug 29; 21(1):59.
    View in: PubMed
    Score: 0.048
  22. Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies. Lancet Respir Med. 2024 Aug; 12(8):633-641.
    View in: PubMed
    Score: 0.047
  23. Tuberculosis screening in immigrant children. Pediatr Infect Dis J. 2004 Jan; 23(1):71-2.
    View in: PubMed
    Score: 0.046
  24. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. Lancet Infect Dis. 2023 04; 23(4):e122-e137.
    View in: PubMed
    Score: 0.043
  25. Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 05 19; 14(1):52.
    View in: PubMed
    Score: 0.041
  26. Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. Eur Respir J. 2021 09; 58(3).
    View in: PubMed
    Score: 0.039
  27. Tuberculosis endotypes to guide stratified host-directed therapy. Med. 2021 03 12; 2(3):217-232.
    View in: PubMed
    Score: 0.037
  28. Challenging the management of drug-resistant tuberculosis - Authors' reply. Lancet. 2020 03 07; 395(10226):783-784.
    View in: PubMed
    Score: 0.035
  29. Immunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania. Pediatr Infect Dis J. 2019 04; 38(4):333-339.
    View in: PubMed
    Score: 0.033
  30. Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J Infect Dis. 2012 May 15; 205 Suppl 2:S209-15.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.